Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-01-18
2011-01-18
Rawlings, Stephen L (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S023100
Reexamination Certificate
active
07871775
ABSTRACT:
The present invention is directed to the identification of markers that can be used to determine whether tumors are sensitive or resistant to a therapeutic agent. The present invention is also directed to the identification of therapeutic targets. The invention features a number of “sensitivity markers.” These are markers that are expressed in most or all cell lines that are sensitive to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are resistant to treatment with that agent. The invention also features a number of “resistance markers.” These are markers that are expressed in most or all cell lines that are resistant to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are sensitive to treatment with that agent. The invention also features marker sets that can predict patients that are likely to respond or not to respond to an agent.
REFERENCES:
patent: 7338758 (2008-03-01), Clark et al.
patent: 2003/0143552 (2003-07-01), Clark et al.
Selvanayagam et al. (Cancer Gen. Cytogen. 2004; 154: 63-66).
Sakamoto et al. (Hum. Cell. Dec. 2001; 14 (4): 305-315).
Huang et al. (Mol. Cancer Ther. Aug. 2002; 1: 769-776).
Lavarino et al. (J. Clin. Oncol. Dec. 2000; 18 (23): 3936-3945).
Bonaldo et al., “Normalization and subtraction: two approaches to facilitate gene discovery”,Genome Res., 6:791-806 (1996).
Hartley et al., “DNA cloning using in vitro site-specific recombination”,Genome Res., 10:1788-1795 (2000).
Nagase et al., “Prediction of the coding sequences of unidentified human genes. Xx. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro”,DNA Research, 8:85-95 (2001).
Simpson et al., “Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing”,EMBO Reports, 11(31):287-292 (2000).
Wiemann et al., “Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs”,Genome Res., 11:422-435 (2001).
GenBank Accession No. NT—030059, Jun. 10, 2009.
GenBank Accession No. NM—032439, Mar. 4, 2010.
Swiss-Prot Accession No. Q96FC7, Apr. 20, 2010.
Genbank Accession No. BAB47425.1, Jun. 5, 2001.
GenBank Accession No. NP—115815, Mar. 4, 2010.
GenBank Accession No. NP—001137246, Mar. 4, 2010.
GenBank Accession No. NM—001143774, Mar. 4, 2010.
GenBank Accession No. AC—025038, Apr. 9, 2002.
Bast, Jr. Robert C.
Brown Jeffrey L.
Clark Edwin
Grenfell-Lee Tallessyn
Hartmann Lynn
Board of Regents , The University of Texas System
Jones Alexandra
Laccotripe Zacharakis Maria
Mayo Foundation for Medical Edication and Research
McCarter & English LLP
LandOfFree
Compositions and methods for the identification, assessment,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the identification, assessment,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the identification, assessment,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2664931